Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

One participant lost 22% of her weight in nine months — substantially faster than the rate seen with approved GLP-1 drugs ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Obesity affects over a third of Missouri's adults and children, with rural areas hit hardest. It's a complex issue linked to mental health and accessibility, not just personal choice.

Dr. Cheryl Kendall discusses urgent pediatric health concerns, offering solutions for childhood obesity and digital addiction ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

For many Americans, day-to-day survival comes before diet and lifestyle considerations. Kale is off the table.

For Kristian Cook, every pizza box he opened was another door closed on the path to overcoming obesity. “I had massive ...

As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial ...

British patients with obesity undergoing hip and knee replacements had less of a need for subsequent revision when, after surgery, they lost weight by using medications such as GLP-1 receptor agonists ...

(HealthDay News) — The number of US adults with severe obesity increased from 2013 to 2023, according to a research letter published online Feb. 13 in the Journal of the American Medical Association.

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.